Summary & Overview
CPT 68130: Conjunctival and Scleral Lesion Excision
CPT code 68130 denotes surgical excision of a conjunctival lesion with removal of adjacent scleral tissue, performed to alleviate pain, reduce pressure, and often to improve visual function. Nationally, this code is relevant to ophthalmology and oculoplastic surgical services that manage ocular surface tumors, degenerations, and painful lesions. It affects hospital outpatient departments and ambulatory surgical centers that provide specialized eye surgery. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when the procedure is used, typical sites of service, and an overview of reimbursement and coding considerations where available. The publication also outlines common billing modifiers and the role of this procedure within ophthalmic surgical practice. Data not available in the input is noted where specific benchmarking, associated taxonomies, ICD-10 pairings, and related codes would otherwise appear.
Billing Code Overview
CPT code 68130 describes a surgical procedure in which the provider excises a lesion on the conjunctiva along with the adjacent scleral tissue to relieve pain and pressure and often to improve vision. This procedure is a form of ocular surface surgery focused on removal of conjunctival and superficial scleral pathology.
-
Service type: Surgical excision of conjunctival and scleral lesion
-
Typical site of service: Hospital outpatient department or ambulatory surgical center where ophthalmic surgeries are performed
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old with a painful, elevated conjunctival-scleral lesion (e.g., a symptomatic conjunctival neoplasm, recurrent pterygium with scleral involvement, or painful scleral staphyloma) causing ocular discomfort, photophobia, localized thinning, or visual axis encroachment. The patient presents to an ophthalmology clinic after conservative measures (topical lubrication, anti-inflammatory drops) fail or diagnostic biopsy suggests excision is indicated. Preoperative assessment includes visual acuity, intraocular pressure, slit-lamp examination documenting lesion size, location, and scleral involvement, and informed consent discussing risks (bleeding, infection, globe perforation, scarring). On the day of service the patient undergoes regional or local anesthesia with monitored sedation as needed. The surgeon performs full-thickness excision of the conjunctival lesion with underlying involved scleral tissue to relieve pain, repair structural integrity, and when possible improve vision. Specimens may be submitted for pathology. Postoperative care includes topical antibiotics, corticosteroids, ocular surface protection, pain control, and scheduled follow-up visits to monitor healing and watch for recurrence. Typical sites of service are outpatient ophthalmic surgical centers, ambulatory surgical centers, or hospital operating rooms depending on patient comorbidity and complexity. This procedure is classified as surgical ophthalmology service and commonly involves ophthalmologists with oculoplastic or corneal subspecialty expertise.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 |